SCHEMBL8285338

SCHEMBL8285338

Cc1cc2c(c(C(=O)N(C)C)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.38
GAA P10253 3/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
GFER P55789 1/20 0.37
MAPT P10636 3/20 0.37
SLC2A1 P11166 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MAT2A P31153 1/20 0.35
CDK4 P11802 2/20 0.35
CCND1 P24385 2/20 0.35
TSHR P16473 2/20 0.34
TAAR1 Q96RJ0 1/20 0.34
NPC1 O15118 2/20 0.34
CSF1R P07333 1/20 0.34
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871681 0.90 PDE11A (0.36) PDE11AGAAHPGDMAPK1GFER
SCHEMBL5871645 0.89 GAA (0.42) PDE11AGAAHPGDMAPK1GFER
SCHEMBL5872094 0.88 PDE11A (0.40) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287996 0.87 MAPT (0.43) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8286146 0.87 PDE11A (0.39) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8287217 0.86 RIPK1 (0.43) PDE11AHPGDMAPTALDH1A1LMNA
SCHEMBL8287992 0.84 SLC2A1 (0.38) PDE11AGAAHPGDMAPK1GFER
SCHEMBL5871724 0.84 CSF1R (0.49) GAAHPGDMAPTALDH1A1HTT
SCHEMBL5872043 0.84 GAA (0.41) PDE11AGAAHPGDMAPK1GFER
SCHEMBL8286168 0.83 PDE11A (0.38) PDE11AGAAHPGDMAPK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed